39589881|t|Early disruption of the CREB pathway drives dendritic morphological alterations in FTD/ALS cortical neurons.
39589881|a|Synaptic loss and dendritic degeneration are common pathologies in several neurodegenerative diseases characterized by progressive cognitive and/or motor decline, such as Alzheimer's disease (AD) and frontotemporal dementia/amyotrophic lateral sclerosis (FTD/ALS). An essential regulator of neuronal health, the cAMP-dependent transcription factor CREB positively regulates synaptic growth, learning, and memory. Phosphorylation of CREB by protein kinase A (PKA) and other cellular kinases promotes neuronal survival and maturation via transcriptional activation of a wide range of downstream target genes. CREB pathway dysfunction has been strongly implicated in AD pathogenesis, and recent data suggest that impaired CREB activation may contribute to disease phenotypes in FTD/ALS as well. However, the mechanisms behind reduced CREB activity in FTD/ALS pathology are not clear. In this study, we found that cortical-like neurons derived from iPSC lines carrying the hexanucleotide repeat expansion in the C9ORF72 gene, a common genetic cause of FTD/ALS, displayed a diminished activation of CREB, resulting in decreased dendritic and synaptic health. Importantly, we determined such impairments to be mechanistically linked to an imbalance in the ratio of regulatory and catalytic subunits of the CREB activator PKA and to be conserved in C9-ALS patient's postmortem tissue. Modulation of cAMP upstream of this impairment allowed for a rescue of CREB activity and an amelioration of dendritic morphology and synaptic protein levels. Our data elucidate the mechanism behind early CREB pathway dysfunction and discern a feasible therapeutic target for the treatment of FTD/ALS and possibly other neurodegenerative diseases.
39589881	24	28	CREB	Gene	1385
39589881	83	86	FTD	Disease	MESH:D057180
39589881	87	90	ALS	Disease	MESH:D008113
39589881	109	122	Synaptic loss	Disease	MESH:D012183
39589881	127	149	dendritic degeneration	Disease	MESH:D007635
39589881	184	210	neurodegenerative diseases	Disease	MESH:D019636
39589881	240	270	cognitive and/or motor decline	Disease	MESH:D003072
39589881	280	299	Alzheimer's disease	Disease	MESH:D000544
39589881	301	303	AD	Disease	MESH:D000544
39589881	309	332	frontotemporal dementia	Disease	MESH:D057180
39589881	333	362	amyotrophic lateral sclerosis	Disease	MESH:D000690
39589881	364	367	FTD	Disease	MESH:D057180
39589881	368	371	ALS	Disease	MESH:D008113
39589881	421	425	cAMP	Chemical	-
39589881	457	461	CREB	Gene	1385
39589881	541	545	CREB	Gene	1385
39589881	716	720	CREB	Gene	1385
39589881	773	775	AD	Disease	MESH:D000544
39589881	828	832	CREB	Gene	1385
39589881	884	887	FTD	Disease	MESH:D057180
39589881	888	891	ALS	Disease	MESH:D008113
39589881	940	944	CREB	Gene	1385
39589881	957	960	FTD	Disease	MESH:D057180
39589881	961	964	ALS	Disease	MESH:D008113
39589881	1117	1124	C9ORF72	Gene	203228
39589881	1157	1160	FTD	Disease	MESH:D057180
39589881	1161	1164	ALS	Disease	MESH:D008113
39589881	1203	1207	CREB	Gene	1385
39589881	1409	1413	CREB	Gene	1385
39589881	1451	1457	C9-ALS	Disease	MESH:C565165
39589881	1458	1465	patient	Species	9606
39589881	1501	1505	cAMP	Chemical	-
39589881	1558	1562	CREB	Gene	1385
39589881	1691	1695	CREB	Gene	1385
39589881	1779	1782	FTD	Disease	MESH:D057180
39589881	1783	1786	ALS	Disease	MESH:D008113
39589881	1806	1832	neurodegenerative diseases	Disease	MESH:D019636
39589881	Negative_Correlation	MESH:D057180	1385
39589881	Positive_Correlation	MESH:D057180	203228
39589881	Association	MESH:C565165	1385
39589881	Association	MESH:D000544	1385
39589881	Association	MESH:D008113	203228
39589881	Negative_Correlation	MESH:D008113	1385

